203 related articles for article (PubMed ID: 33989722)
1. Update on brain MRI for the diagnosis and follow-up of MS patients.
Brisset JC; Vukusic S; Cotton F;
Presse Med; 2021 Jun; 50(2):104067. PubMed ID: 33989722
[TBL] [Abstract][Full Text] [Related]
2. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.
Brisset JC; Kremer S; Hannoun S; Bonneville F; Durand-Dubief F; Tourdias T; Barillot C; Guttmann C; Vukusic S; Dousset V; Cotton F;
J Neuroradiol; 2020 Jun; 47(4):250-258. PubMed ID: 32014494
[TBL] [Abstract][Full Text] [Related]
3. OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol.
Cotton F; Kremer S; Hannoun S; Vukusic S; Dousset V;
J Neuroradiol; 2015 Jun; 42(3):133-40. PubMed ID: 25660217
[TBL] [Abstract][Full Text] [Related]
4. The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK.
Fernandes L; Allen CM; Williams T; Tallantyre E; Evangelou N; Chataway J; Ford HL;
Mult Scler Relat Disord; 2021 Oct; 55():103190. PubMed ID: 34365316
[TBL] [Abstract][Full Text] [Related]
5. [Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations].
Cruz A; Pereira D; Batista S
Acta Med Port; 2024 Jan; 37(1):53-63. PubMed ID: 38183232
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for the management of multiple sclerosis relapses.
Laplaud D; Bodiguel E; Bensa C; Blanc F; Brassat D; Magy L; Ouallet JC; Zephir H; De Seze J;
Rev Neurol (Paris); 2012 May; 168(5):425-33. PubMed ID: 22555010
[TBL] [Abstract][Full Text] [Related]
7. Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.
Vukusic S; Casey R; Rollot F; Brochet B; Pelletier J; Laplaud DA; De Sèze J; Cotton F; Moreau T; Stankoff B; Fontaine B; Guillemin F; Debouverie M; Clanet M
Mult Scler; 2020 Jan; 26(1):118-122. PubMed ID: 30541380
[TBL] [Abstract][Full Text] [Related]
8. Consensus recommendations on the management of multiple sclerosis patients in Argentina.
Cristiano E; Rojas JI; Alonso R; Alvez Pinheiro A; Bacile EA; Balbuena ME; Barboza AG; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Curbelo MC; Deri N; Fernandez Liguori N; Gaitán MI; Garcea O; Giunta D; Halfon MJ; Hryb JP; Jacobo M; Kohler E; Luetic GG; Maglio I; Martínez AD; Míguez J; Nofal PG; Patrucco L; Piedrabuena R; Rotta Escalante R; Saladino ML; Silva BA; Sinay V; Tkachuk V; Villa A; Vrech C; Ysrraelit MC; Correale J
J Neurol Sci; 2020 Feb; 409():116609. PubMed ID: 31816524
[TBL] [Abstract][Full Text] [Related]
9. [A current view on the MRI diagnosis of multiple sclerosis: an update of 2016 revised MRI criteria].
Bryukhov VV; Krotenkova IA; Morozova SN; Krotenkova MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):66-73. PubMed ID: 28617364
[TBL] [Abstract][Full Text] [Related]
10. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
Oh J; Gagné-Brosseau MS; Guenette M; Larochelle C; Lemieux F; Menon S; Morrow SA; Poliquin-Lasnier L; Roy-Hewitson C; Rush C; Trudelle AM; Giacomini PS
Can J Neurol Sci; 2018 May; 45(3):304-312. PubMed ID: 29756588
[TBL] [Abstract][Full Text] [Related]
11. Survey of diagnostic and treatment practices for multiple sclerosis in Europe.
Fernández O; Delvecchio M; Edan G; Fredrikson S; Gionvannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
Eur J Neurol; 2017 Mar; 24(3):516-522. PubMed ID: 28139062
[TBL] [Abstract][Full Text] [Related]
12. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.
Cocozza S; Pontillo G; Lanzillo R; Russo C; Petracca M; Di Stasi M; Paolella C; Vola EA; Criscuolo C; Moccia M; Lamberti A; Monti S; Brescia Morra V; Elefante A; Palma G; Tedeschi E; Brunetti A
Neuroradiology; 2019 Feb; 61(2):155-162. PubMed ID: 30617409
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.
Layne KA; Dargan PI; Archer JRH; Wood DM
Br J Clin Pharmacol; 2018 Nov; 84(11):2522-2534. PubMed ID: 30032482
[TBL] [Abstract][Full Text] [Related]
14. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.
Wilson S; Calocer F; Rollot F; Fauvernier M; Remontet L; Tron L; Vukusic S; Le Page E; Debouverie M; Ciron J; Ruet A; De Sèze J; Zephir H; Moreau T; Lebrun-Frénay C; Laplaud DA; Clavelou P; Labauge P; Berger E; Pelletier J; Heinzlef O; Thouvenot E; Camdessanché JP; Leray E; Dejardin O; Defer G
Lancet Reg Health Eur; 2023 Jan; 24():100542. PubMed ID: 36426377
[TBL] [Abstract][Full Text] [Related]
15. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
Wattjes MP; Ciccarelli O; Reich DS; Banwell B; de Stefano N; Enzinger C; Fazekas F; Filippi M; Frederiksen J; Gasperini C; Hacohen Y; Kappos L; Li DKB; Mankad K; Montalban X; Newsome SD; Oh J; Palace J; Rocca MA; Sastre-Garriga J; Tintoré M; Traboulsee A; Vrenken H; Yousry T; Barkhof F; Rovira À; ; ;
Lancet Neurol; 2021 Aug; 20(8):653-670. PubMed ID: 34139157
[TBL] [Abstract][Full Text] [Related]
16. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
Miller DH; Grossman RI; Reingold SC; McFarland HF
Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
[TBL] [Abstract][Full Text] [Related]
17. What is the Relevance of the Systematic Use of Gadolinium During the MRI Follow-Up of Multiple Sclerosis Patients Under Natalizumab?
Bellanger G; Biotti D; Patsoura S; Ciron J; Ferrier M; Gramada R; Meluchova Z; Lerebours F; Catalaa I; Dumas H; Cognard C; Brassat D; Bonneville F
Clin Neuroradiol; 2020 Sep; 30(3):553-558. PubMed ID: 31143968
[TBL] [Abstract][Full Text] [Related]
18. The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers.
Brocard G; Casey R; Dufay N; Marignier R; Michel L; Hisbergues M; Ayrignac X; Lehmann S; Thouvenot E; Gallot G; Collongues N; Herpe YE; Lebrun-Frenay C; Cotton F; De Sèze J; Guillemin F; Moreau T; Pelletier J; Stankoff B; Vukusic S; Zephir H; Laplaud D;
Mult Scler Relat Disord; 2023 Sep; 77():104872. PubMed ID: 37453261
[TBL] [Abstract][Full Text] [Related]
19. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
Traboulsee A; Simon JH; Stone L; Fisher E; Jones DE; Malhotra A; Newsome SD; Oh J; Reich DS; Richert N; Rammohan K; Khan O; Radue EW; Ford C; Halper J; Li D
AJNR Am J Neuroradiol; 2016 Mar; 37(3):394-401. PubMed ID: 26564433
[TBL] [Abstract][Full Text] [Related]
20. Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice.
Oreja-Guevara C;
Eur J Neurol; 2015 Oct; 22 Suppl 2():22-7. PubMed ID: 26374510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
